Member News

Read the latest news from the MassBio community! This space is for members to share company updates and press releases. Members may not post stories that are copyrighted by news publications or post sales pitches.

Worldwide medtech sales forecast to reach $595 billion by 2024, with a CAGR of 5.6%, anchored by familiar players EvaluatePharma USA, Inc. October 3, 2018

The global medtech industry is forecast to grow at a CAGR of 5.6% from 2017 to 2024 and reach $595 billion in sales by 2024, according to the latest report from Evaluate Ltd. Read More

An Important Medical Device Regulation Update from Australia Australian Trade and Investment Commission September 4, 2018

In an exciting development for North American companies, the TGA, Australia’s regulatory body for therapeutic goods, has released new guidance on accepted overseas approvals on medical devices. Read More

Small drug developers continue to hold all the cards, while young device makers suffer from a shrinking pool of buyers EvaluatePharma USA, Inc. August 28, 2018

The first half of 2018 has seen biopharma IPOs and venture financing accelerate from the already-healthy levels witnessed in 2017. Deal making has dimmed further, however, raising concern. Read More

Versatope wins big at Massachusetts Life Science Innovators Day Versatope June 25, 2018

Versatope Therapeutics, Inc., received the first prize at the 11th Massachusetts Life Science Innovators (MALSI) conference that took place at the Harvard Club in Boston on May 31, 2018. Read More

Worldwide prescription drug sales accelerate to $1.2 trillion by 2024, as unmet need drives annual compound growth to over 6% EvaluatePharma USA, Inc. June 19, 2018

Orphan drugs are forecast to remain one of the fastest growth areas of the global pharmaceutical market according to Evaluate’s annual industry report. Read More

Asymmetrex Revs Up Continuing Education Campaign for Stem Cell Dose Standardization Asymmetrex, LLC June 6, 2018

Asymmetrex founder and director James Sherley addresses the importance and challenges of introducing stem cell dose standardization into regenerative medicine practice. Read More

Asymmetrex Establishes Partnership with Contract Research Organization DRIK Asymmetrex, LLC June 5, 2018

Stem cell biotechnology company Asymmetrex and preclinical toxicology CRO DRIK have formed a new partnership for addressing a significant unmet need in the pharmaceutical and cell therapy industries. Read More

Donna L. LaVoie to Deliver Workshop at BIO International Convention LaVoie Strategic Communications Group Inc. May 24, 2018

Donna L. LaVoie to Deliver Workshop at BIO International Convention: How to Tell Your Company Story in Just 15 Slides Read More

RowAnalytics Secures Seed Funding for its precisionlife AI Enabled Data Analytics Business RowAnalytics March 8, 2018

RowAnalytics has secured seed round investment from global investors Astia Angels and Wheatsheaf Group Ltd, part of the Grosvenor Estate. Read More

Mealplanner and MediSapiens Receive EU Grant for Joint Project to Prevent the Onset of Diabetes MediSapiens Inc. January 16, 2018

The Mealplanner™ have partnered with MediSapiens to develop an application for helping users in the prevention of onset of type 2 diabetes. Read More